Yes, the list still exists.

On Tue, Mar 5, 2019 at 1:00 AM jc u <[log in to unmask]> wrote:

> Hello,
>
> Does this list still exist? If not, is there an alternate list or social
> media platform?
>
> Thank you for your reply.
>
>
>
>
>
> > On Jul 12, 2018, at 1:28 PM, Rayilyn Brown <[log in to unmask]> wrote:
> >
> > Parkinson's News Today Daily Digest
> >
> > From: Parkinson's News Today
> > Sent: Thursday, July 12, 2018 8:04 AM
> > To: =?utf-8?Q??=
> > Subject: Parkinson's News Today Daily Digest
> >
> >                  See below for a daily digest of the latest Parkinson's
> Disease news & perspectives! Is this email not displaying correctly?
> >                  View it in your browser.
> >
> >
> >
> >                        Parkinson's News Today Daily Digest
> >                        Contents:
> >
> >                          a.. More Than 1 Million Cases of Parkinson’s
> Predicted in the US by 2030, Study Reports
> >                          b.. Mirapex Sustained Release Tablet
> Outperforms Immediate Release Version to Relieve Sleep Disturbances
> >
> >                              More Than 1 Million Cases of Parkinson’s
> Predicted in the US by 2030, Study Reports
> >                              Jul 12, 2018 07:00 am | Alice Melão
> >
> >                              Approximately 1.2 million people in the
> United States are predicted to have Parkinson’s disease by the year 2030,
> according to the results of a large-scale study. This represents a
> projected increase by about 1.8 times in Parkinson’s prevalence since 2010,
> highlighting the need for optimized care and treatment strategies for this
> patient population to diminish the burden […]
> >
> >                              The post More Than 1 Million Cases of
> Parkinson’s Predicted in the US by 2030, Study Reports appeared first on
> Parkinson's News Today.
> >
> >                                Read More
> >
> >
> >                              Mirapex Sustained Release Tablet
> Outperforms Immediate Release Version to Relieve Sleep Disturbances
> >                              Jul 12, 2018 07:00 am | Jose Marques Lopes,
> PhD
> >
> >                              Sustained release formulation of
> pramipexole (Mirapex, Boehringer Ingelheim) outperforms its immediate
> release alternative to treat sleep disturbances in advanced Parkinson’s
> patients, a new study suggests. The research, “Comparison of nocturnal
> symptoms in advanced Parkinson’s disease patients with sleep disturbances:
> pramipexole sustained release versus immediate release formulations,” was
> published in Drug Design, Development and Therapy. Sleep disturbances,
> which may include […]
> >
> >                              The post Mirapex Sustained Release Tablet
> Outperforms Immediate Release Version to Relieve Sleep Disturbances
> appeared first on Parkinson's News Today.
> >
> >                                Read More
> >
> >
> >
> >
> >
> >                        Recent Posts
> >                        ‘You Don’t Look Sick’
> >                        PBT434 Prevents Neuron Loss, Improves Motor
> Function in Animal Model of Neurodegeneration, Prana Reports
> >                        3D Structure of Alpha-Synuclein Challenges
> Previous Theory of Parkinson’s
> >                        Herantis Announces New Program to Develop
> Non-Invasive CDNF for Parkinson’s Treatment
> >                        Where Does Your Strength Come From?
> >
> >
> >
> >
> >
> >
> >                  Copyright © 2018 BioNews Services, LLC, All rights
> reserved.
> >                  You are receiving this email because you opted in at
> our website http://parkinsonsnewstoday.com/
> >
> >                  Our mailing address is:
> >
> >                  BioNews Services, LLC
> >                  5307 E. Mockingbird Ln.
> >                  Fifth Floor
> >                  Dallas, TX 75206
> >
> >                  Add us to your address book
> >                  unsubscribe from this list | update subscription
> preferences
> >
> >
> >
> >
> > ----------------------------------------------------------------------
> > To sign-off Parkinsn send a message to: mailto:
> [log in to unmask]
> > In the body of the message put: signoff parkinsn
> >
>
> ----------------------------------------------------------------------
> To sign-off Parkinsn send a message to: mailto:
> [log in to unmask]
> In the body of the message put: signoff parkinsn
>

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn